» Articles » PMID: 27685105

Characteristics of Quantitative Perfusion Parameters on Dynamic Contrast-enhanced MRI in Mammographically Occult Breast Cancer

Overview
Date 2016 Sep 30
PMID 27685105
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this study was to compare the characteristics of quantitative per-fusion parameters obtained from dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) in patients with mammographically occult (MO) breast cancers and those with mammographically visible (MV) breast cancers. Quantitative parameters (AUC, Ktrans, kep, ve, vp, and wi) from 13 MO breast cancers and 16 MV breast cancers were mapped after the DCE-MRI data were acquired. Various prog-nostic factors, including axillary nodal status, estrogen receptor (ER), progesterone receptor (PR), Ki-67, p53, E-cadherin, and human epidermal growth factor receptor 2 (HER2) were obtained in each group. Fisher's exact test was used to compare any differences of the various prognostic factors between the two groups. The Mann- Whitney U test was applied to compare the quantitative parameters between these two groups. Finally, Spearman's correlation was used to investigate the relation-ships between perfusion indices and four factors - age, tumor size, Ki-67, and p53 - for each group. Although age, tumor size, and the prognostic factors were not statistically different between the two groups, the mean values of the quantitative parameters, except wi in the MV group, were higher than those in the MO group without statistical significance (p = 0.219). The kep value was significantly differ-ent between the two groups (p = 0.048), but the other parameters were not. In the MO group, vp with size, ve with p53, and Ktrans and vp with Ki-67 had significant correlations (p < 0.05). However, in the MV group, only kep showed significant correlation with age. The kep value was only the perfusion parameter of statistical significance between MO and MV breast cancers.

Citing Articles

Occult breast cancer in an older woman: A case report.

Liu C, Xing H Exp Ther Med. 2025; 29(2):38.

PMID: 39781192 PMC: 11707571. DOI: 10.3892/etm.2024.12788.


Vascularity and Dynamic Contrast-Enhanced Breast Magnetic Resonance Imaging.

Frankhouser D, Dietze E, Mahabal A, Seewaldt V Front Radiol. 2023; 1:735567.

PMID: 37492179 PMC: 10364989. DOI: 10.3389/fradi.2021.735567.


High-temporal resolution DCE-MRI improves assessment of intra- and peri-breast lesions categorized as BI-RADS 4.

Liu Y, Wang S, Qu J, Tang R, Wang C, Xiao F BMC Med Imaging. 2023; 23(1):58.

PMID: 37076817 PMC: 10116788. DOI: 10.1186/s12880-023-01015-4.


Breast PET/MRI Hybrid Imaging and Targeted Tracers.

Romeo V, Helbich T, Pinker K J Magn Reson Imaging. 2022; 57(2):370-386.

PMID: 36165348 PMC: 10074861. DOI: 10.1002/jmri.28431.


Value of magnetic resonance diffusion combined with perfusion imaging techniques for diagnosing potentially malignant breast lesions.

Zhang H, Zhang X, Wang Y World J Clin Cases. 2022; 10(18):6021-6031.

PMID: 35949832 PMC: 9254209. DOI: 10.12998/wjcc.v10.i18.6021.


References
1.
Murase K . Efficient method for calculating kinetic parameters using T1-weighted dynamic contrast-enhanced magnetic resonance imaging. Magn Reson Med. 2004; 51(4):858-62. DOI: 10.1002/mrm.20022. View

2.
Cho N, Moon W, Chang J, Yi A, Koo H, Han B . Sonographic characteristics of breast cancers detected by supplemental screening US: Comparison with breast cancers seen on screening mammography. Acta Radiol. 2010; 51(9):969-76. DOI: 10.3109/02841851.2010.515615. View

3.
Padhani A . Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. J Magn Reson Imaging. 2002; 16(4):407-22. DOI: 10.1002/jmri.10176. View

4.
El Khouli R, Macura K, Kamel I, Jacobs M, Bluemke D . 3-T dynamic contrast-enhanced MRI of the breast: pharmacokinetic parameters versus conventional kinetic curve analysis. AJR Am J Roentgenol. 2011; 197(6):1498-505. PMC: 3496793. DOI: 10.2214/AJR.10.4665. View

5.
Kim J, Kim S, Kim Y, Kang B, Yi An Y, Lee A . Enhancement parameters on dynamic contrast enhanced breast MRI: do they correlate with prognostic factors and subtypes of breast cancers?. Magn Reson Imaging. 2014; 33(1):72-80. DOI: 10.1016/j.mri.2014.08.034. View